sdü tıp fak derg Medical Journal of Süleyman Demirel University 2602-2109 Süleyman Demirel Üniversitesi 10.17343/sdutfd.969715 Surgery Cerrahi CERRAHİ REZEKSİYON YAPILAN KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERLİ KADIN HASTALARDA SAĞKALIMA ETKİ EDEN PROGNOSTİK FAKTÖRLER PROGNOSTIC FACTORS FOR THE SURVIVAL OF SURGICALLY TREATED FEMALE PATIENTS FOR NON-SMALL CELL LUNG CANCER https://orcid.org/0000-0003-1269-7442 Aker Cemal SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL YEDİKULE GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ https://orcid.org/0000-0002-2461-2031 Sezen Celal Buğra SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL YEDİKULE GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ https://orcid.org/0000-0002-2722-3058 Dogru Mustafa Vedat SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL YEDİKULE GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ https://orcid.org/0000-0003-1030-7906 Demirkol Ece Yasemin SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL YEDİKULE GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ https://orcid.org/0000-0002-8799-476X Erduhan Semih SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL YEDİKULE GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ https://orcid.org/0000-0003-0210-6899 Erk Melek SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL YEDİKULE GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ https://orcid.org/0000-0002-0744-4531 Sönmezoğlu Yaşar SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL YEDİKULE GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ https://orcid.org/0000-0002-5171-6805 Saydam Özkan SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL YEDİKULE GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ https://orcid.org/0000-0003-4928-1790 Cansever Levent SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL YEDİKULE GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ https://orcid.org/0000-0003-0804-2654 Metin Muzaffer SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL YEDİKULE GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ 12 30 2021 28 4 673 680 07 11 2021 07 28 2021 Copyright © 1994, Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi 1994 Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi

AmaçBu çalışmadaki amacımız, küçük hücreli dışı akciğerkanseri (KHDAK) nedeniyle rezeksiyon uygulanmışhastalarda prognostik faktörlerin cinsiyete bağlı olaraketkilerinin ve kadınlarda sağkalıma etki eden faktörlerinliteratür eşliğinde değerlendirilmesidir.Gereç ve YöntemÇalışmaya Ocak 2007-Aralık 2018 yılları arasındahastanemizde KHDAK nedeniyle akciğer rezeksiyonuuygulanmış hastalar dahil edilmiştir.1491 hasta çalışmayadahil edilmiştir.BulgularHastaların ortalama yaşı 60,0±8,41 (aralık:26-84)yıl idi. 1324 (%88,8) erkek hasta, 167 (%11,2) kadınhasta çalışmada mevcuttu. 406 (%27,2) hastayapnömonektomi, 1077 (%72,2) hastaya lobektomi ve 8hastaya (%0,5) segmentektomi yapılmıştır. Ortalama5 yıllık sağkalım süresi % 57.5 idi. Çalışmada kadınhastaların 5 yıllık sağkalım oranı %66,8 iken erkeklerde%56,4 idi (p=0.005). pN2 durumu değerlendirildiğinde5 yıllık sağkalım oranı %34,3 iken, pN0 olanhastalarda sağkalım oranı %64,1 olarak saptanmıştır(p

ObjectiveThis study aims to evaluate the effects of prognosticfactors depending on gender and the factors affectingsurvival in women patients who underwent resection fornon-small cell lung cancer (NSCLC).Material and MethodsPatients who underwent lung resection due to NSCLCin our hospital between January 2007 and December2018 were included in the study. 1491 patients wereincluded in the study.ResultsThe mean age of the patients was 60.0±8.41 (range:26-84) years. There were 1324 (88.8%) male patientsand 167 (11.2%) female patients. Pneumonectomywas performed in 406 (27.2%) patients, lobectomyin 1077 (72.2%) patients, and segmentectomy in 8patients (0.5%). The mean 5-year survival time was57.5%. In the study, the 5-year survival rate of femalepatients was 66.8%, while it was 56.4% in males(p=0.005). When the pN2 status was evaluated, the5-year survival rate was 34.3%, while the survival ratewas 64.1% in patients with pN0 (p

 Akciğer Kanseri Sağkalım Prognostik Faktörler Lung Cancer Survival Prognostic Factors 1. Didkowska J, Wojciechowska U, Mańczuk M, Łobaszewski J. Lung cancer epidemiology: contemporary and future challenges worldwide. Ann Transl Med. 2016;4(8). 2. Sezen CB, Kalafat CE, Doğru MV, Aker C, Erdogu V, Saydam O, et al. The Effect of Lymph Node Ratio on Survival in Non- Small-Cell Lung Cancer. Acta Chir Belg. 2021;(just-accepted): 1–18. 3. Locher C, Debieuvre D, Coëtmeur D, Goupil F, Molinier O, Collon T, et al. Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies. Lung Cancer. 2013;81(1):32–8. 4. Lautamäki A, Gunn J, Sipilä J, Rautava P, Sihvo E, Kytö V. Women have a higher resection rate for lung cancer and improved survival after surgery. Interact Cardiovasc Thorac Surg. 2021;32(6):889–95. 5. Fibla JJ, Molins L, Quero F, Izquierdo JM, Sánchez D, Hernández J, et al. Perioperative outcome of lung cancer surgery in women: results from a Spanish nationwide prospective cohort study. J Thorac Dis. 2019;11(4):1475. 6. Belot A, Fowler H, Njagi EN, Luque-Fernandez M-A, Maringe C, Magadi W, et al. Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population- based study. Thorax. 2019;74(1):51–9. 7. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4(5):568–77. 8. Radkiewicz C, Dickman PW, Johansson ALV, Wagenius G, Edgren G, Lambe M. Sex and survival in non-small cell lung cancer: A nationwide cohort study. PLoS One. 2019;14(6):e0219206. 9. Nakamura H, Ando K, Shinmyo T, Morita K, Mochizuki A, Kurimoto N, et al. Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis. Ann Thorac Cardiovasc Surg. 2011;17(5):469–80. 10. Sakurai H, Asamura H, Goya T, Eguchi K, Nakanishi Y, Sawabata N, et al. Survival differences by gender for resected nonsmall cell lung cancer: A retrospective analysis of 12,509 cases in a Japanese lung cancer registry study. J Thorac Oncol. 2010;5(10):1594–601. 11. Chatkin JM, Abreu CM, Fritscher CC, Wagner MB, Pinto JALF. Is there a gender difference in non-small cell lung cancer survival? Gend Med. 2004;1(1):41–7. 12. Cerfolio RJ, Bryant AS, Scott E, Sharma M, Robert F, Spencer SA, et al. Women with pathologic stage I, II, and III nonsmall cell lung cancer have better survival than men. Chest. 2006;130(6):1796–802. 13. Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39–51. 14. Yoshida Y, Murayama T, Sato Y, Suzuki Y, Saito H, Nomura Y. Gender differences in long-term survival after surgery for non-small cell lung Cancer. Thorac Cardiovasc Surg. 2016;64(06):507–14. 15. van Rens MTM, van den Bosch JMM, de la Rivière AB, Elbers HRJ. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest. 2000;117(2):374–9. 16. Bonanno L, Attili I, Pavan A, Sepulcri M, Pasello G, Rea F, et al. Treatment strategies for locally advanced non-small cell lung cancer in elderly patients: translating scientific evidence into clinical practice. Crit Rev Oncol Hematol. 2021;103378. 17. Kalathiya RJ, Saha SP. Pneumonectomy for non-small cell lung cancer: outcomes analysis. South Med J. 2012;105(7):350–4. 18. Alexiou C, Beggs D, Rogers ML, Beggs L, Asopa S, Salama FD. Pneumonectomy for non-small cell lung cancer: predictors of operative mortality and survival. Eur J cardio-thoracic Surg. 2001;20(3):476–80. 19. Aker C, Sezen CB, Ceritoglu A, Dogru MV, Aksoy Y, Kalafat CE, et al. Prognostic value of Glasgow Prognostic Score in patients with non-small cell lung cancers undergoing pN2 pneumonectomy. Curr Thorac Surg. 4(1). 20. Dogru MV, Sezen CB, Aker C, Girgin O, Kilimci U, Erduhan S, et al. Evaluation of Factors Affecting Morbidity and Mortality in Pneumonectomy Patients. Acta Chir Belg. 2020;(just-accepted): 1–16. 21. Caldarella A, Crocetti E, Comin CE, Janni A, Pegna AL, Paci E. Gender differences in non-small cell lung cancer: a population- based study. Eur J Surg Oncol. 2007;33(6):763–8. 22. Hsu L-H, Chu N-M, Liu C-C, Tsai SYC, You D-L, Ko J-S, et al. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor? Lung Cancer. 2009;66(2):262–7.